HomeAFP • ASX
add
AFT Pharmaceuticals Ltd
Previous close
$2.55
Year range
$2.15 - $3.53
Market cap
310.90M NZD
Avg Volume
1.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NZE
In the news
Financials
Income Statement
Revenue
Net income
| (NZD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 43.36M | 3.71% |
Operating expense | 19.00M | 16.26% |
Net income | -1.09M | -220.37% |
Net profit margin | -2.52 | -216.13% |
Earnings per share | — | — |
EBITDA | -538.50K | -128.84% |
Effective tax rate | 13.49% | — |
Balance Sheet
Total assets
Total liabilities
| (NZD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.69M | 73.14% |
Total assets | 147.89M | -6.91% |
Total liabilities | 64.36M | -24.25% |
Total equity | 83.53M | — |
Shares outstanding | 104.87M | — |
Price to book | 3.19 | — |
Return on assets | -1.52% | — |
Return on capital | -1.92% | — |
Cash Flow
Net change in cash
| (NZD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.09M | -220.37% |
Cash from operations | 2.18M | -41.71% |
Cash from investing | -1.97M | 18.70% |
Cash from financing | -791.00K | 51.61% |
Net change in cash | -677.00K | -92.33% |
Free cash flow | -2.36M | -52.12% |
About
Founded
1997
Website
Employees
110
